ArQule, Inc. (ARQL)
$3.49
0.19 (+5.76%)
| CAPS Rating |
|
|---|---|
| Open | $3.41 |
| Previous Close | $3.30 |
| Daily Range | $3.24 - $3.51 |
| 52-Week Range | $2.22 - $6.38 |
| Market Cap | $155.96M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 417,912 |
| Average Daily Volume | 196,000 |
ARQL
VS S&P 500 (SPY)
How do you think ARQL will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ARQL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ARQL News and Commentary
- ArQule, Inc.: Warming Up or Cooling Off? – The Motley Fool
- UPDATE 1- ArQule Q3 beats estimates, sees narrower '09 loss – Reuters
- 6 Stocks Losing Top Investor Support – The Motley Fool
- My Watchlist for this week - Jan 26 – Blog at The Motley Fool
- Ugly lessons from Biotech: Exelixis – Blog at The Motley Fool
- Making Cents in Penny Stocks – The Motley Fool
- Closing ARQL (Arqule) underperform – Blog at The Motley Fool
- A Little Bit of Cash for ArQule – The Motley Fool
- 4 Biotech Bets Under $10 – The Motley Fool
- Exelixis Gets Marching Orders – The Motley Fool
- Do You See What I WuXi? – The Motley Fool
- Contrarian Shopping List – The Motley Fool
- Dendreon Tries to Pick Up the Pieces – The Motley Fool
- Diagnosing Dendreon Postmortem – The Motley Fool
- A Universe of Great Stocks – The Motley Fool
Related News and Articles
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
RSS Headlines
Fool UK
